SLC5A1
protein-codingsolute carrier family 5 member 1, the group of Solute carrier family 5
Gene summary
This gene encodes a member of the sodium-dependent glucose transporter (SGLT) family. The encoded integral membrane protein is the primary mediator of dietary glucose and galactose uptake from the intestinal lumen. Mutations in this gene have been associated with glucose-galactose malabsorption. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
- SGLT1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~69.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0011731
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011731
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0011731
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0011731
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Gastrointestinal
Intervention: Gastrointestinal
Rationale: Individuals typically present in infancy with severe osmotic diarrhea and consequent dehydration, which can be fatal without dietary elimination of glucose and galactose (ie, individuals demonstrate dramatic improvement on fructose-based formula)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SLC5A1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000343.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 130 | 2 | 138 | ||
| missense | 3 | 15 | 168 | 11 | 1 | 198 |
| nonsense | 9 | 5 | 14 | |||
| start loss | 1 | 1 | ||||
| frameshift | 5 | 5 | 10 | |||
| splice donor/acceptor (+/-2bp) | 1 | 10 | 1 | 12 | ||
| Total | 18 | 36 | 175 | 141 | 3 | 373 |
Highest pathogenic variant AF is 0.00004036247
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000334.1 | 15 | MANE Select | |
| Ensembl | ENSP00000266088.4 | 15 | MANE Select | |
| RefSeq | NP_001243243.1 | 11 | Standard | |
| Ensembl | ENSP00000444898.1 | 11 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Bile secretion - Homo sapiens (human)
- Carbohydrate digestion and absorption - Homo sapiens (human)
- Mineral absorption - Homo sapiens (human)
- Trehalose Degradation
- Lactose Degradation
Biological Process
- sodium ion transport
- intestinal hexose absorption
- glucose transmembrane transport
Molecular Function
- glucose:sodium symporter activity
- protein binding
Cellular Component
- plasma membrane
- integral component of plasma membrane
- integral component of membrane
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000266088
- Coding exons
- 15
- Length
- 69998
- Individuals with no LoFs
- 125705
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 43
- Defined
- 125748
- p
- 0.000171
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.83 | 274 | 374 | 0.733 | 0.0000226 | 4322 |
| Missense (PolyPhen) | 62 | 130.55 | 0.47492 | 1524 | ||
| Synonymous | -0.385 | 151 | 145 | 1.04 | 0.00000960 | 1328 |
| Loss of Function | 2.59 | 17 | 33.1 | 0.514 | 0.00000171 | 387 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0.00017 | 0.00017 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00023 | 0.00023 | rare |
| South Asian | 0.00016 | 0.00016 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Actively transports glucose into cells by Na(+) cotransport with a Na(+) to glucose coupling ratio of 2:1. Efficient substrate transport in mammalian kidney is provided by the concerted action of a low affinity high capacity and a high affinity low capacity Na(+)/glucose cotransporter arranged in series along kidney proximal tubules.;
- Disease
- DISEASE: Congenital glucose/galactose malabsorption (GGM) [MIM:606824]: Intestinal monosaccharide transporter deficiency. It is an autosomal recessive disorder manifesting itself within the first weeks of life. It is characterized by severe diarrhea and dehydration which are usually fatal unless glucose and galactose are eliminated from the diet. {ECO:0000269|PubMed:10036327, ECO:0000269|PubMed:11406349, ECO:0000269|PubMed:2008213, ECO:0000269|PubMed:8195156}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.405
Intolerance Scores
- LoFtool
- 0.0773
- RVIS EVS
- 0.33
- RVIS percentile EVS
- 73.61
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.649
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |